Schedule 13G ownership disclosure
ANTHERA PHARMACEUTCLS INC
Security class unavailable · CUSIP: 03674U201
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,897,479
- Percent of class
- 3.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-17-002986
- Form type
- SC 13G
- Filer
- Anthera Pharmaceuticals Inc
- CIK
- CIK 1316175
- Filed
- Apr 10, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership